Under the microscope: Antisense Therapeutics (ASX:ANP) and Neuren Pharmaceuticals (ASX:NEU)

https://is1-ssl.mzstatic.com/image/thumb/Podcasts221/v4/e0/9b/f4/e09bf45a-b30f-b87c-8f2d-29f5e88a1201/mza_5616139513584150856.jpg/600x600bb.jpg

Morgans Under the Microscope

Morgans Financial Limited

96 episodes

14 hours ago

A series of podcasts that include interviews with executives from ASX-listed companies and updates on the healthcare sector.

Investing

Business

RSS

All content for Morgans Under the Microscope is the property of Morgans Financial Limited and is served directly from their servers with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.

A series of podcasts that include interviews with executives from ASX-listed companies and updates on the healthcare sector.

Investing

Business

https://d3wo5wojvuv7l.cloudfront.net/t_rss_itunes_square_1400/images.spreaker.com/original/b24e052c6c3c13fc1383eb8152d86dc5.jpg

Under the microscope: Antisense Therapeutics (ASX:ANP) and Neuren Pharmaceuticals (ASX:NEU)

Morgans Under the Microscope

5 minutes

4 years ago

Under the microscope: Antisense Therapeutics (ASX:ANP) and Neuren Pharmaceuticals (ASX:NEU)

Morgans analyst Iain Wilkie discusses the healthcare team's initiation of coverage for Antisense Therapeutics (ASX:ANP) and highlights Neuren Pharmaceuticals (ASX:NEU) as a stock with key catalysts ahead.

Check out more from Morgans:
Visit the Morgans website: www.morgans.com.au
Check out our blog: www.morgans.com.au/Blog

On Facebook: www.facebook.com/MorgansAU
On Instagram: www.instagram.com/morgans.australia
On Twitter: twitter.com/morgansAU